Analyze Diet
EFSA journal. European Food Safety Authority2024; 22(4); e8730; doi: 10.2903/j.efsa.2024.8730

Safety and efficacy of a feed additive consisting of a tincture derived from the roots of Panax ginseng C.A.Mey. (ginseng tincture) for horses, dogs and cats (FEFANA asbl).

Abstract: Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of a tincture from the roots of C.A.Mey. (ginseng tincture), when used as a sensory additive in feed for horses, dogs and cats. The product is a water/ethanol (40:60 v/v) solution, with a dry matter content of no more than 6% and a content of 0.01%-0.5% (w/w) for the sum of the two triterpene saponins ginsenoside Rb1 and ginsenoside Rg1. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the tincture is safe for horses, dogs and cats at the maximum proposed use level of 48.6, 228.7 and 162 mg/kg complete feed, respectively. The Panel also concluded that the additive is considered safe for consumers when used at the proposed conditions of use in feed for horses. Ginseng tincture should be considered as an irritant to skin and eyes, and as a dermal and respiratory sensitiser. The use of the ginseng tincture as a flavour in feed for horses was not expected to pose a risk for the environment. Since the roots of and its preparations were recognised to flavour food and their function in feed would be essentially the same, no demonstration of efficacy was considered necessary.
Publication Date: 2024-04-08 PubMed ID: 38591023PubMed Central: PMC11000137DOI: 10.2903/j.efsa.2024.8730Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research is about a study conducted by the European Food Safety Agency (EFSA) to understand the safe and effective usage of a tincture derived from ginseng roots in animal feed for horses, dogs, and cats.

Research Objective

  • The objective of this research was to analyze and evaluate the safety and effectiveness of a tincture extracted from the roots of Panax Ginseng. This is primarily used as a sensory additive in the feed for horses, dogs, and cats.

Product Description

  • The product under scrutiny is a water and ethanol (ratio 40:60 v/v) solution with minimal dry matter content of around 6%. The product further comprises 0.01-0.5% of the sum of two triterpenes saponins, ginsenoside Rb1, and ginsenoside Rg1. These compounds are biologically active compounds produced mainly by plants with beneficial effects on health.

Safety Analysis

  • The team, led by the FEEDAP panel, concluded after their examination that this tincture derived from ginseng roots was safe to use as feed for cats, dogs, and horses at the proposed use levels of 48.6, 228.7, and 162 mg/kg of complete feed, respectively.
  • In addition to the safety of the animals, consideration was also given to the safety of consumers who would consume these animals. Under the specified conditions of use, the additive was deemed safe for human consumption, especially when used in feed for horses.

Potential Risks

  • While the tincture was deemed safe for animal feed, the panel also identified potential risks. It was found that the ginseng tincture could cause skin and eye irritation and might sensitize the skin and respiratory system.
  • However, no environmental risks were identified from its potential use in horse feed.

Efficacy Evaluation

  • The EFSA did not expect the ginseng tincture to demonstrate a unique efficacy as it is already recognized for its flavor-enhancing capabilities in food products. Its purpose in animal feed was assumed to be essentially the same.

Conclusions

  • In conclusion, the research deemed the ginseng tincture safe and effective for use in animal feed for horses, dogs, and cats. While potential health risks were identified for skin and respiratory system sensitization, the overall evaluation substantiated safe consumer consumption and minimal impact on the environment.

Cite This Article

APA
Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Kouba M, López-Alonso M, Puente SL, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Villa RE, Woutersen R, Brantom P, Chesson A, Schlatter J, Westendorf J, Dirven Y, Manini P, Dusemund B. (2024). Safety and efficacy of a feed additive consisting of a tincture derived from the roots of Panax ginseng C.A.Mey. (ginseng tincture) for horses, dogs and cats (FEFANA asbl). EFSA J, 22(4), e8730. https://doi.org/10.2903/j.efsa.2024.8730

Publication

ISSN: 1831-4732
NlmUniqueID: 101642076
Country: United States
Language: English
Volume: 22
Issue: 4
Pages: e8730
PII: e8730

Researcher Affiliations

Bampidis, Vasileios
    Azimonti, Giovanna
      Bastos, Maria de Lourdes
        Christensen, Henrik
          Durjava, Mojca
            Kouba, Maryline
              López-Alonso, Marta
                Puente, Secundino López
                  Marcon, Francesca
                    Mayo, Baltasar
                      Pechová, Alena
                        Petkova, Mariana
                          Ramos, Fernando
                            Villa, Roberto Edoardo
                              Woutersen, Ruud
                                Brantom, Paul
                                  Chesson, Andrew
                                    Schlatter, Josef
                                      Westendorf, Johannes
                                        Dirven, Yvette
                                          Manini, Paola
                                            Dusemund, Birgit

                                              Conflict of Interest Statement

                                              If you wish to access the declaration of interests of any expert contributing to an EFSA scientific assessment, please contact interestmanagement@efsa.europa.eu.

                                              References

                                              This article includes 49 references
                                              1. Abdel‐Aziem SH, Hassan AM, Abdel‐Wahhab MA. Dietary supplementation with whey protein and ginseng extract counteracts oxidative stress and DNA damage in rats fed an aflatoxin‐contaminated diet. Mutation Research, Genetic Toxicology and Environmental Mutagenesis 723, 65–71.
                                              2. Burdock GA. Fenaroli's handbook of flavor ingredients (6th ed.). .
                                                doi: 10.1201/9781439847503google scholar: lookup
                                              3. Chung EW, Kwok WH, Leung DKK, Leung GNW, Tang FPW, Wan TSM, Steward BD, Watkins K. Detection and confirmation of ginsenosides in horse urine by GC–MS and LC–MS. Chromatographia 69, 923–932.
                                                doi: 10.1365/s10337-009-1034-ygoogle scholar: lookup
                                              4. Court MH, Greenblatt DJ. Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes. Biochemical Pharmacology 53, 1041–1047.
                                                doi: 10.1016/s0006-2952(97)00072-5pubmed: 9174118google scholar: lookup
                                              5. Cramer GM, Ford RA, Hall RL. Estimation of toxic hazard–a decision tree approach. Food and Cosmetics Toxicology 16, 255–276.
                                                doi: 10.1016/s0015-6264(76)80522-6pubmed: 357272google scholar: lookup
                                              6. EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids). Scientific opinion on flavouring group evaluation 82, revision 1 (FGE.82Rev1): Consideration of epoxides evaluated by the JECFA (65th meeting). EFSA Journal 12(6), 3708.
                                                doi: 10.2903/j.efsa.2014.3708google scholar: lookup
                                              7. EFSA CEP Panel (EFSA Panel on Food Contact Materials, Enzymes and Processing Aids), Silano V, Barat Baviera JM, Bolognesi C, Chesson A, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, Mortensen A, Rivière G, Steffensen I‐L, Tlustos C, Van Loveren H, Vernis L, Zorn H, Cravedi J‐P, Fortes C, Castle L. Scientific opinion on the update of the risk assessment of di‐butylphthalate (DBP), butyl‐benzyl‐phthalate (BBP), bis(2‐ethylhexyl)phthalate (DEHP), di‐isononylphthalate (DINP) and di‐isodecylphthalate (DIDP) for use in food contact materials. EFSA Journal 17(12), 5838.
                                                doi: 10.2903/j.efsa.2019.5838pmc: PMC7008866pubmed: 32626195google scholar: lookup
                                              8. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed). Guidance for the preparation of dossiers for sensory additives. EFSA Journal 10(1), 2534.
                                                doi: 10.2903/j.efsa.2012.2534google scholar: lookup
                                              9. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed). Scientific opinion on the safety and efficacy of aliphatic, alicyclic and aromatic saturated and unsaturated tertiary alcohols and esters with esters containing tertiary alcohols ethers (chemical group 6) when used as flavourings for all animal species. EFSA Journal 10(11), 2966.
                                                doi: 10.2903/j.efsa.2012.2966google scholar: lookup
                                              10. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed). Scientific opinion on the safety and efficacy of straight‐chain primary aliphatic alcohols/aldehydes/acids, acetals and esters with esters containing saturated alcohols and acetals containing saturated aldehydes (chemical group 01) when used as flavourings for all animal species. EFSA Journal 11(4), 3169.
                                                doi: 10.2903/j.efsa.2013.3169google scholar: lookup
                                              11. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed). Scientific opinion on the safety and efficacy of aliphatic and aromatic hydrocarbons (chemical group 31) when used as flavourings for all animal species. EFSA Journal 13(3), 4053.
                                                doi: 10.2903/j.efsa.2015.4053google scholar: lookup
                                              12. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed). Scientific opinion on the safety and efficacy of aliphatic and aromatic hydrocarbons (chemical group 31) when used as flavourings for all animal species and categories. EFSA Journal 14(1), 4339.
                                                doi: 10.2903/j.efsa.2016.4339google scholar: lookup
                                              13. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed). Scientific opinion on the safety and efficacy of α,β‐unsaturated straight‐chain and branched‐chain aliphatic primary alcohols, aldehydes, acids and esters belonging to chemical group 3 when used as flavourings for all animal species. EFSA Journal 14(6), 4512.
                                                doi: 10.2903/j.efsa.2016.4512pmc: PMC7009239pubmed: 32626273google scholar: lookup
                                              14. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Innocenti ML. Guidance on the identity, characterisation and conditions of use of feed additives. EFSA Journal 15(10), 5023.
                                                doi: 10.2903/j.efsa.2017.5023pmc: PMC7010039pubmed: 32625313google scholar: lookup
                                              15. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Martino L. Guidance on the assessment of the safety of feed additives for the target species. EFSA Journal 15(10), 5021.
                                                doi: 10.2903/j.efsa.2017.5021pmc: PMC7009839pubmed: 32625311google scholar: lookup
                                              16. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Innocenti ML. Guidance on the assessment of the safety of feed additives for the consumer. EFSA Journal 15(10), 5022.
                                                doi: 10.2903/j.efsa.2017.5022google scholar: lookup
                                              17. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Martino L. Guidance on the assessment of the efficacy of feed additives. EFSA Journal 16(5), 5274.
                                                doi: 10.2903/j.efsa.2018.5274pmc: PMC7009555pubmed: 32625911google scholar: lookup
                                              18. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Bampidis V, Bastos ML, Christensen H, Dusemund B, Kouba M, Kos Durjava M, López‐Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Brock T, Knecht J, Azimonti G. Guidance on the assessment of the safety of feed additives for the environment. EFSA Journal 17(4), 5648.
                                                doi: 10.2903/j.efsa.2019.5648pmc: PMC7009194pubmed: 32626279google scholar: lookup
                                              19. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Dusemund B, Kouba M, López‐Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Villa RE, Woutersen R, Brantom P, Chesson A, Galobart J. Guidance on the assessment of the safety of feed additives for the users. EFSA Journal 21(12), e8469.
                                                doi: 10.2093/j.efsa.2023.8469pmc: PMC10698700pubmed: 38075627google scholar: lookup
                                              20. EFSA SC (EFSA Scientific Committee). Guidance on safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements, on request of EFSA. EFSA Journal 7(9), 1249.
                                                doi: 10.2093/j.efsa.2009.1249google scholar: lookup
                                              21. EFSA SC (EFSA Scientific Committee), More SJ, Hardy A, Bampidis V, Benford D, Bennekou SH, Bragard C, Boesten J, Halldorsson TI, Hernandez‐Jerez AF, Jeger MJ, Knutsen HK, Koutsoumanis KP, Naegeli H, Noteborn H, Ockleford C, Ricci A, Rychen G, Schlatter JR, Hogstrand C. Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals. EFSA Journal 17(3), 5634.
                                                doi: 10.2903/j.efsa.2019.5634pmc: PMC7009070pubmed: 32626259google scholar: lookup
                                              22. EFSA SC (EFSA Scientific Committee), More S, Bampidis V, Benford D, Boesten J, Bragard C, Halldorsson T, Hernandez‐Jerez A, Hougaard‐Bennekou S, Koutsoumanis K, Naegeli H, Nielsen SS, Schrenk D, Silano V, Turck D, Younes M, Aquilina G, Crebelli R, Gürtler R, Schlatter J. Statement on the genotoxicity assessment of chemical mixtures. EFSA Journal 17(1), 5519.
                                                doi: 10.2903/j.efsa.2019.5519pmc: PMC7009058pubmed: 32626066google scholar: lookup
                                              23. EFSA SC (EFSA Scientific Committee), More SJ, Bampidis V, Benford D, Bragard C, Halldorsson TI, Hernandez‐Jerez AF, Hougaard BS, Koutsoumanis KP, Machera K, Naegeli H, Nielsen SS, Schlatter JR, Schrenk D, Silano V, Turck D, Younes M, Gundert‐Remy U, Kass GEN, Wallace HM. Guidance on the use of the threshold of toxicological concern approach in food safety assessment. EFSA Journal 17(6), 5708.
                                                doi: 10.2903/j.efsa.2019.5708pmc: PMC7009090pubmed: 32626331google scholar: lookup
                                              24. EMA (European Medicines Agency), Committee on herbal medicinal products (HMPC). Assessment report on Panax ginseng C.A. Meyer, radix. EMA/HMPC/321232/2012.
                                              25. EMA (European Medicines Agency), Committee on herbal medicinal products (HMPC). Community herbal monograph on Panax ginseng C.A.Mey., aetheroleum. EMA/HMPC/321185/2012.
                                              26. EMEA (European Medicines Agency), Committee for medicinal products for veterinary. Summary report on ginseng. EMEA/MRL/669/99‐Final.
                                              27. EMEA (European Medicines Agency), Committee for medicinal products for veterinary. Summary report on ginseng (extension of use) committee for medicinal products for veterinary. EMEA/CVMP/352217/2006‐Final.
                                              28. Gu Y, Wang GJ, Sun JG, Jia YW, Wang W, Xu MJ, Lv T, Zheng YT, Sai Y. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs. Food and Chemical Toxicology 47(9), 2257–2268.
                                                doi: 10.1016/j.fct.2009.06.013pubmed: 19524010google scholar: lookup
                                              29. Gusson F, Carletti M, Giuliano Albo A, Dacasto M, Nebbia C. Comparison of hydrolytic and conjugative biotransformations pathways in horse, cattle, pig, broiler chick, rabbit and rat liver subcellular fractions. Veterinary Research Communications 30, 271–283.
                                                pubmed: 16437303
                                              30. Jeong MK, Cho CK, Yoo HS. General and genetic toxicology of enzyme‐treated ginseng extract: Toxicology of ginseng Rh2. Journal of Pharmacopuncture 19, 213–224.
                                                doi: 10.3831/KPI.2016.19.022pmc: PMC5043085pubmed: 27695630google scholar: lookup
                                              31. Lautz LS, Jeddi MZ, Girolami F, Nebbia C, Dorne JLCM. Metabolism and pharmacokinetics of pharmaceuticals in cats (Felix sylvestris catus) and implications for the risk assessment of feed additives and contaminants. Toxicology Letters 338, 114–127.
                                                doi: 10.1016/j.toxlet.2020.11.014pubmed: 33253781google scholar: lookup
                                              32. Lee J, Jeong JS, Cho KJ, Moon KN, Kim SY, Han B, Kim YS, Jeong EJ, Chung MK, Yu WJ. Developmental and reproductive toxicity assessment in rats with KGC‐HJ3, Korean Red Ginseng with Angelica gigas and Deer antlers. Journal of Ginseng Research 43, 242–251.
                                                doi: 10.1016/j.jgr.2017.12.004pmc: PMC6437469pubmed: 30976162google scholar: lookup
                                              33. Li L, Chen X, Li D, Zhong D. Identification of 20(S)‐protopanaxadiol metabolites in human liver microsomes and human hepatocytes. Drug Metabolism and Disposition: The Biological Fate of Chemicals 39, 472–483.
                                                doi: 10.1124/dmd.110.036723pubmed: 21139039google scholar: lookup
                                              34. Munro IC, Ford RA, Kennepohl E, Sprenger JG. Correlation of structural class with no‐observed‐effect levels: A proposal for establishing a threshold of concern. Food and Chemical Toxicology 34, 829–867.
                                                doi: 10.1016/s0278-6915(96)00049-xpubmed: 8972878google scholar: lookup
                                              35. NTP (National Toxicology Program). NTP technical report on the toxicology and carcinogenesis studies of ginseng (CAS No. 50647–08‐0) in F344/N rats and B6C3F1 mice (gavage studies). NTP, technical report series 567 NIH publication no. 11‐5909, National Institutes of Health, U.S. Department of Health and Human Services.
                                                pubmed: 21921964
                                              36. Park JS, Kim SH, Han KM, Kim YS, Kwon E, Paek SH, Seo YK, Yun JW, Kang BC. Efficacy and safety evaluation of black ginseng (Panax ginseng C.A. Mey.) extract (CJ EnerG): Broad spectrum cytotoxic activity in human cancer cell lines and 28‐day repeated oral toxicity study in Sprague‐Dawley rats. BMC Complementary Medicine and Therapies 22, 44.
                                                doi: 10.1186/s12906-022-03522-3pmc: PMC8848956pubmed: 35172794google scholar: lookup
                                              37. Park SJ, Lim KH, Noh JH, Jeong EJ, Kim YS, Han BC, Lee SH, Moon KS. Subacute oral toxicity study of Korean red ginseng extract in Sprague‐Dawley rats. Toxicological Research 29, 285–292.
                                                doi: 10.5487/TR.2013.29.4.285pmc: PMC3936181pubmed: 24578799google scholar: lookup
                                              38. Park SJ, Noh J, Jeong EJ, Kim YS, Han BC, Lee SH, Moon KS. Subchronic oral toxicity study of Korean red ginseng extract in Sprague‐Dawley rats with a 4‐week recovery period. Regulatory Toxicology and Pharmacology 92, 83–93.
                                                doi: 10.1016/j.yrtph.2017.11.007pubmed: 29155077google scholar: lookup
                                              39. PhEur (European Pharmacopoeia). Ginseng extractum siccum. European pharmacopoeia (11th ed.) Monograph 01/2013:2356.
                                              40. PhEur (European Pharmacopoeia). Ginseng radix. European pharmacopoeia (11th ed.) Monograph 07/2019:1827.
                                              41. PhEur Commentary. Ginsengwurzel. Ginseng radix. Kommentar zur Ph. Eur. 7.0. In Bracher F., Heisig P., Langguth P., Mutschler E., Rücker G., Scriba G. K. E., Stahl‐Biskup E., & Troschütz R. (Eds.), Arzneibuch‐Kommentar: Wissenschaftliche Erlauterungen zum Arzneibuch (Commentary to the European Pharmacopeia). Wissenschaftliche Verlagsgesellschaft.
                                              42. Rhee YH, Ahn JH, Choe J, Kang KW, Joe C. Inhibition of mutagenesis and transformation by root extracts of Panax ginseng in vitro. Planta Medica 57, 125–128.
                                                doi: 10.1055/s-2006-960047pubmed: 1891494google scholar: lookup
                                              43. Seo HW, Suh JH, So S‐H, Kyung J‐S, Kim Y‐S, Han C‐K. Subacute oral toxicity and bacterial mutagenicity study of Korean Red Ginseng oil. Journal of Ginseng Research 41, 595–601.
                                                doi: 10.1016/j.jgr.2017.01.009pmc: PMC5628349pubmed: 29021709google scholar: lookup
                                              44. Sun D, Wang B, Shi M, Zhang YX, Zhou LF, Liu ZR, Wu ZL, Jiang W, Han JL, Xiong LZ, Zhao G. Pharmacokinetic, tissue distribution and excretion of ginsenoside‐Rd in rodents. Phytomedicine 19, 369–373.
                                                doi: 10.1016/j.phymed.2011.08.061pubmed: 21899993google scholar: lookup
                                              45. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws L, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walker N, Peterson RE. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin‐like compounds. Toxicological Sciences 93, 223–241.
                                                doi: 10.1093/toxsci/kfl055pmc: PMC2290740pubmed: 16829543google scholar: lookup
                                              46. WHO (World Health Organization). Radix ginseng. WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). iris.who.int/handle/10665/44059.
                                              47. Xia C, Wang G, Sun J, Hao H, Xiong Y, Gu S, Shang L, Zheng C. Simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat plasma by liquid chromatography/electrospray ionization mass spectrometric method and its application to pharmacokinetic study of ‘SHENMAI’ injection. Journal of Chromatography B 862, 72–78.
                                                doi: 10.1016/j.jchromb.2007.11.020pubmed: 18083641google scholar: lookup
                                              48. Yu K, Ma Y, Shao Q, Qu H, Cheng Y. Simultaneously determination of five ginsenosides in rabbit plasma using solid‐phase extraction and HPLC/MS technique after intravenous administration of ‘SHENMAI’ injection. Journal of Pharmaceutical and Biomedical Analysis 44, 532–539.
                                                doi: 10.1016/j.jpba.2007.01.032pubmed: 17317071google scholar: lookup
                                              49. Zhao J, Su C, Yang C, Liu M, Tang L, Su W, Liu Z. Determination of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: Application in a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 64-65, 94–97.
                                                doi: 10.1016/j.jpba.2012.02.017pubmed: 22421407google scholar: lookup

                                              Citations

                                              This article has been cited 0 times.